The global sales of central venous catheters (CVC) are estimated to be valued at USD 2,861.0 million in 2024 and are expected to reach USD 5,436.8 million by 2034. This growth represents a compound annual growth rate (CAGR) of 6.6% over the forecast period.
In 2023, the revenue generated by peripherally inserted central catheters (PICC) reached USD 2,694.1 million, highlighting the increasing adoption of these medical devices in various healthcare settings. Central venous catheters are essential for administering long-term medication, fluids, and nutrition to patients with critical conditions. As the demand for advanced healthcare services rises, along with the growing prevalence of chronic diseases requiring intravenous therapy, the CVC market is expected to experience strong and sustained growth.
The market for central venous catheters has been witnessing an unexpected boom due to the growing demand from critical care, oncology, and intervention procedures. CVCs have become an indispensable device in the delivery of drugs, fluids, and nutrients into the bloodstream, while the most common application of these catheters is for hemodynamic monitoring or blood sampling. The demand for central venous catheters has seen a rise in different fields of practice like CCUs, amongst others, even in long-term treatments such as chemotherapy and dialysis.
The improvement in the catheter material, infection-resistant coating, and insertion techniques has enabled better patient outcomes with a reduction in complications associated with catheters due to vascular dysfunction or infection.
In addition to the above factors, more healthcare professionals-surgeons, anesthesiologists, and interventional radiologists-are favoring minimally invasive procedures, which further enhances demand for CVCs. They will be set to continue to grow due to the rise of chronic disease and population aging, as they play a very important role in both primary and specialty care.
Competitive Landscape
Substantial investments in the central venous catheter market are increasingly focused on acquisitions and expansion to drive growth and strengthen market presence. Companies are prioritizing the acquisition of innovative technologies and products to enhance their offerings, while also pursuing strategic partnerships to expand their global footprint.
Recent Industry Developments in Central Venous Catheter Market
- In December 2021, BD (Becton, Dickinson and Company), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England.
- In January 2022, ICU Medical Inc. completed its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical business includes syringe and ambulatory infusion devices, vascular access, and vital care products.
Key Players of Central Venous Catheter Industry
- Becton, Dickinson and Company
- Teleflex Incorporated
- B. Braun Melsungen AG
- AngioDynamics, Inc.
- Medtronic Plc.
- Smiths Medical (ICU Medical Inc.)
- Cook Group
- Vygon S.A.
- Argon Medical Devices, Inc.
- KIMAL PLC
- Lepu Medical Technology (Beijing) Co., Ltd. (Comed B.V.)
- Merit Medical Systems, Inc.
- Fresenius Medical Care AG & Co. KGaA
- Medical Components, Inc.
- Integer Holdings Corporation
- Biomerics
- Heka s.r.l.
Full Report Revealed
Key Segments of Central Venous Catheter Industry
By Product Type:
In terms of product type, the industry is divided into peripherally inserted central catheters (PICC), implanted port, tunneled central venous catheters and non-tunneled central venous catheters.
By Design:
In terms of design, the industry is segregated into single lumen, double lumen, and multiple lumen.
By Composition:
In terms of Composition, the industry is segregated into polyurethane, Teflon and silicone rubber.
By End-User:
The industry is classified by end user as hospitals, ambulatory surgical centers, specialized clinics and cancer research institutes.
By Region:
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
